Global and United States Guaifenesin API Powder Market Report & Forecast 2022-2028

Guaifenesin API Powder is used to relieve chest congestion. Guaifenesin may help control symptoms but does not treat the cause of symptoms or speed recovery. Guaifenesin is in a class of medications called expectorants. It works by thinning the mucus in the air passages to make it easier to cough up the mucus and clear the airways.
Market Analysis and Insights: Global and United States Guaifenesin API Powder Market
This report focuses on global and United States Guaifenesin API Powder market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Guaifenesin API Powder market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, >99% accounting for % of the Guaifenesin API Powder global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Pharmaceuticals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Guaifenesin API Powder market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Guaifenesin API Powder Scope and Market Size
Guaifenesin API Powder market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Guaifenesin API Powder market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Guaifenesin API Powder market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
>99%
98%-99%
Segment by Application
Pharmaceuticals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Granules
Synthokem Labs
Haizhou Pharma
Yuan Cheng Group
Stellar Chemical
Seven Star Pharma
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Delta Synthetic
Smart Pharm